Answers are grounded in this paper and cite their sources.
Retrospective analysis describes costs and healthcare resource utilization linked to CDKL5 deficiency disorder, suggesting important insights for management.
To describe costs, healthcare resource utilization (HCRU), and patient characteristics associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in the MarketScan database.
No takes yet. Share an insight, caveat, or question.
Khushalani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: